279 related articles for article (PubMed ID: 29222306)
1. Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents.
Ferreri AJM
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):565-577. PubMed ID: 29222306
[TBL] [Abstract][Full Text] [Related]
2. Treatment Options for Recurrent Primary CNS Lymphoma.
Kaulen LD; Baehring JM
Curr Treat Options Oncol; 2022 Nov; 23(11):1548-1565. PubMed ID: 36205806
[TBL] [Abstract][Full Text] [Related]
3. Have treatment protocols for primary CNS lymphoma advanced in the past 10 years.
Seidel S; Schlegel U
Expert Rev Anticancer Ther; 2019 Oct; 19(10):909-915. PubMed ID: 31594423
[No Abstract] [Full Text] [Related]
4. Successful treatment of isolated central nervous system recurrence of primary testicular lymphoma by autologous stem cell transplantation using a conditioning regimen of thiotepa and busulfan.
Tanaka Y; Sakai T; Tsunemine H; Ito T; Arima N
J Clin Exp Hematop; 2024 Mar; 64(1):32-36. PubMed ID: 38417873
[TBL] [Abstract][Full Text] [Related]
5. Consolidation Therapy in Primary Central Nervous System Lymphoma.
Kim P; Omuro A
Curr Treat Options Oncol; 2020 Jul; 21(9):74. PubMed ID: 32725379
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.
Correa DD; Braun E; Kryza-Lacombe M; Ho KW; Reiner AS; Panageas KS; Yahalom J; Sauter CS; Abrey LE; DeAngelis LM; Omuro A
J Neurooncol; 2019 Sep; 144(3):553-562. PubMed ID: 31377920
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Ferreri AJM; Cwynarski K; Pulczynski E; Fox CP; Schorb E; Celico C; Falautano M; Nonis A; La Rosée P; Binder M; Fabbri A; Ilariucci F; Krampera M; Roth A; Hemmaway C; Johnson PW; Linton KM; Pukrop T; Gørløv JS; Balzarotti M; Hess G; Keller U; Stilgenbauer S; Panse J; Tucci A; Orsucci L; Pisani F; Zanni M; Krause SW; Schmoll HJ; Hertenstein B; Rummel M; Smith J; Thurner L; Cabras G; Pennese E; Ponzoni M; Deckert M; Politi LS; Finke J; Ferranti A; Cozens K; Burger E; Ielmini N; Cavalli F; Zucca E; Illerhaus G;
Leukemia; 2022 Jul; 36(7):1870-1878. PubMed ID: 35562406
[TBL] [Abstract][Full Text] [Related]
8. A Rare Case of Primary Central Nervous System Lymphoma in an Adolescent Female Treated with High-Dose Methotrexate and Rituximab-Based Chemoimmunotherapy and Consolidation Whole Brain Radiotherapy.
Biswas A; Adhikari N; Bakhshi S; Gopinathan VR; Sharma MC
Pediatr Neurosurg; 2019; 54(1):57-65. PubMed ID: 30669145
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.
Grommes C; Rubenstein JL; DeAngelis LM; Ferreri AJM; Batchelor TT
Neuro Oncol; 2019 Feb; 21(3):296-305. PubMed ID: 30418592
[TBL] [Abstract][Full Text] [Related]
10. A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma.
Steffanoni S; Calimeri T; Anzalone N; Mastaglio S; Bernardi M; Ferreri AJ
Expert Rev Hematol; 2022 Jan; 15(1):33-43. PubMed ID: 34904506
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.
Holdhoff M; Mrugala MM; Grommes C; Kaley TJ; Swinnen LJ; Perez-Heydrich C; Nayak L
J Natl Compr Canc Netw; 2020 Nov; 18(11):1571-1578. PubMed ID: 33152700
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system.
Nilius-Eliliwi V; Treiber H; Seidel S; Vangala DB; Schroers R
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5729-5732. PubMed ID: 36566338
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma.
Beca JM; Raza K; Mow E; Keech J; Kouroukis CT
Leuk Lymphoma; 2020 May; 61(5):1097-1107. PubMed ID: 31931647
[TBL] [Abstract][Full Text] [Related]
14. Primary Central Nervous System Lymphomas.
Chukwueke U; Grommes C; Nayak L
Hematol Oncol Clin North Am; 2022 Feb; 36(1):147-159. PubMed ID: 34801161
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience.
Suleman A; Liu J; Hicks LK; Drori AK; Crump M; Kridel R; Prica A; Berinstein N
Haematologica; 2023 Apr; 108(4):1186-1189. PubMed ID: 36453110
[No Abstract] [Full Text] [Related]
16. How we treat primary central nervous system lymphoma.
Calimeri T; Steffanoni S; Gagliardi F; Chiara A; Ferreri AJM
ESMO Open; 2021 Aug; 6(4):100213. PubMed ID: 34271311
[TBL] [Abstract][Full Text] [Related]
17. The Diagnosis and Treatment of Primary CNS Lymphoma.
von Baumgarten L; Illerhaus G; Korfel A; Schlegel U; Deckert M; Dreyling M
Dtsch Arztebl Int; 2018 Jun; 115(25):419-426. PubMed ID: 29999484
[TBL] [Abstract][Full Text] [Related]
18. First line treatments in primary central nervous system lymphomas in young patients.
Schenone L; Alcantara M; Houillier C; Soussain C
Curr Opin Oncol; 2023 Sep; 35(5):357-363. PubMed ID: 37498049
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature.
Gaut D; Schiller GJ
Int J Hematol; 2019 Mar; 109(3):260-277. PubMed ID: 30671909
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based management of primary and secondary CNS lymphoma.
Khwaja J; Nayak L; Cwynarski K
Semin Hematol; 2023 Nov; 60(5):313-321. PubMed ID: 38135609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
